Showing results (71-80 of 176) with videos related to

Sort By:
Pageof 18
Biological Psychiatry|November 7, 2008
A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophreniaW Wolfgang Fleischhacker, Robert D McQuade, Ronald N Marcus, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 3, 2014
Extrapyramidal symptoms during treatment of first schizophrenia episode: results from EUFESTJanusz K Rybakowski, Kristof Vansteelandt, Agnieszka Remlinger-Molenda, et al.
The International Journal of Neuropsychopharmacology|December 21, 2012
Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia TrialW Wolfgang Fleischhacker, Cynthia O Siu, Robert Bodén, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 1, 2012
Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia TrialSilvana Galderisi, Armida Mucci, Istvan Bitter, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 26, 2015
Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studiesPál Czobor, Richard A Van Dorn, Leslie Citrome, et al.
Alcoholism, Clinical and Experimental Research|March 27, 2003
Reduced olfactory sensitivity, discrimination, and identification in patients with alcohol dependenceClaudia I Rupp, Martin Kurz, Georg Kemmler, et al.
Psychiatry Research|December 12, 2018
Self-stigma versus stigma resistance in schizophrenia: Associations with resilience, premorbid adjustment, and clinical symptomsAlex Hofer, Fabienne Post, Silvia Pardeller, et al.
The Journal of Clinical Psychiatry|August 10, 2011
Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST)Jan Volavka, Pal Czobor, Eske M Derks, et al.
Clinical Drug Investigation|July 4, 2012
Paliperidone: a review of clinical trial data and clinical implicationsSheng-Min Wang, Changsu Han, Soo-Jung Lee, et al.
The Journal of Clinical Psychiatry|April 2, 2016
Bilirubin concentration correlates with positive symptoms in patients with schizophreniaChristian G Widschwendter, Maria A Rettenbacher, Georg Kemmler, et al.
Pageof 18